AVACOPAN (Tavneos®)

Clinical Indication

For treating severe active granulomatosis with polyangiitis or microscopic polyangiitis.


In line with NICE TA825


Date of classification

December 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.